The effects of PI3K/Akt/mTOR signaling inhibitors on T-ALL lymphoblast samples, grown in the presence of interleukin-7 (IL-7), were evaluated by first treating the cells with increasing concentrations of the drugs and then analyzing the rates of survival by MTT assays. The gene discussed is IL7; the disease is acute lymphoblastic leukemia.